About Evotec SE (EVT)
Evotec SE is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Hamburg, Germany. EVT has been publicly traded since 1999, giving it 27+ years of trading history.
Evotec SE (EVT) has been publicly traded since 1999, making it a 27-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Hamburg, Germany and employs approximately 4,788 people. With a market capitalization of €742 million, EVT is a smaller company with higher growth potential.
EVT trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a small-cap-cap stock with a market capitalization of approximately €742 million. The company employs approximately 4,788 people worldwide.
Key Statistics
- Current Price
- €4.18
- Market Cap
- €742.09M
- 52-Week High
- €8.57
- 52-Week Low
- €4.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
EVT Investment Performance
EVT has declined 23.4% year-to-date in 2026. Over the past 5 years, a €1,000 investment in EVT would have grown to €136, representing a -86.4% total return. Since its IPO in 1999, a €1,000 investment would now be worth €235.
€1,000 Invested in Evotec SE (EVT)
How much would €1,000 invested in EVT be worth today?
What would €1,000 invested in EVT 1 year ago be worth today?
A €1,000 investment in Evotec SE (EVT) in 2025 would be worth €689 as of March 2026, representing a -31.1% total return.
What would €1,000 invested in EVT 3 years ago be worth today?
A €1,000 investment in Evotec SE (EVT) in 2023 would be worth €215 as of March 2026, representing a -78.5% total return.
What would €1,000 invested in EVT 5 years ago be worth today?
A €1,000 investment in Evotec SE (EVT) in 2021 would be worth €136 as of March 2026, representing a -86.4% total return.
What would €1,000 invested in EVT 10 years ago be worth today?
A €1,000 investment in Evotec SE (EVT) in 2016 would be worth €1,317 as of March 2026, representing a +31.7% total return.
What would €1,000 invested in EVT at IPO be worth today?
A €1,000 investment in Evotec SE (EVT) at IPO would be worth €235 as of March 2026, representing a -76.5% total return.
Monthly Returns Heatmap
Over the past 26+ years (316 months), Evotec SE (EVT) has averaged a monthly return of +1.05% with a median return of -0.69%. The stock had 146 positive months (46%) and 169 negative months (53%). The best month in EVT's history was February 2000 with a +171.2% return, while the worst was March 2000 at -44.2%. Historically, January tends to be the strongest month (averaging +4.7%), and March the weakest (-2.4%).
EVT's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 2000 with a cumulative return of +201.5%, and the worst was 2002 at -144.8%.
Annual Returns
Over 27 years of trading history, Evotec SE (EVT) has delivered an average annual return of +15.02% with a median return of +13.47%. The compound annual growth rate (CAGR) is -5.24%. The stock posted gains in 16 years (59%) and losses in 11 years (41%).
EVT's best year was 2003 with a +180.66% gain, while the worst was 2002 at -82.17%. The longest streak of consecutive positive years was 10, and the longest losing streak was 3 years. EVT achieved double-digit gains (10%+) in 15 years. It suffered double-digit losses in 10 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -23.39% | €5.45 | €4.18 |
| 2025 | -33.50% | €8.19 | €5.45 |
| 2024 | -61.49% | €21.28 | €8.19 |
| 2023 | +39.45% | €15.26 | €21.28 |
| 2022 | -64.09% | €42.50 | €15.26 |
| 2021 | +40.36% | €30.28 | €42.50 |
| 2020 | +31.37% | €23.05 | €30.28 |
| 2019 | +32.74% | €17.36 | €23.05 |
| 2018 | +28.63% | €13.50 | €17.36 |
| 2017 | +81.40% | €7.44 | €13.50 |
| 2016 | +78.47% | €4.17 | €7.44 |
| 2015 | +13.47% | €3.67 | €4.17 |
| 2014 | +0.27% | €3.66 | €3.67 |
| 2013 | +39.57% | €2.63 | €3.66 |
| 2012 | +12.37% | €2.34 | €2.63 |
| 2011 | -19.97% | €2.92 | €2.34 |
| 2010 | +37.09% | €2.13 | €2.92 |
| 2009 | +176.62% | €0.77 | €2.13 |
| 2008 | -66.95% | €2.33 | €0.77 |
| 2007 | -28.31% | €3.25 | €2.33 |
| 2006 | +30.00% | €2.50 | €3.25 |
| 2005 | -4.38% | €2.61 | €2.50 |
| 2004 | -48.23% | €5.05 | €2.61 |
| 2003 | +180.66% | €1.80 | €5.05 |
| 2002 | -82.17% | €10.09 | €1.80 |
| 2001 | -69.52% | €33.10 | €10.09 |
| 2000 | +85.00% | €17.89 | €33.10 |
EVT Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Evotec SE as an investment
Valuation
The forward P/E ratio is -11.6. The price-to-book ratio stands at 0.9. The price-to-sales ratio is 1.0.
Dividends
Evotec SE does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
EVT has a beta of 1.12, indicating it is slightly more volatile than the overall market. The stock's 52-week range is €4.00 to €8.57, and it currently trades near its 52-week low.
Analyst Ratings
Based on 6 analyst opinions, EVT has a consensus "buy" rating. The average price target of €6.97 suggests 66.9% upside from current levels.
Frequently Asked Questions: EVT
What sector is EVT in? ▼
EVT operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has EVT performed historically? ▼
Over 27 years of trading history, EVT has posted gains in 16 years (59% of the time). The best year was 2003 with a +180.7% return. Past performance does not guarantee future results.
How can I invest in EVT? ▼
You can invest in EVT through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold EVT.
Does EVT pay dividends? ▼
Evotec SE does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
What does Evotec SE do? ▼
Evotec SE is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Hamburg, Germany.
What sector is EVT in? ▼
EVT operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did EVT go public? ▼
Evotec SE went public in 1999, making it a 27-year-old public company as of 2026.
How much would €1,000 invested in EVT 5 years ago be worth today? ▼
A €1,000 investment in EVT five years ago would be worth approximately €136 today, representing a -86.4% return.
How much would €1,000 invested in EVT 10 years ago be worth today? ▼
A €1,000 investment in EVT ten years ago would be worth approximately €1,317 today, representing a 31.7% total return over the decade.
What is EVT's 3-year return? ▼
Over the past 3 years, EVT has returned -78.5%. A €1,000 investment would have grown to €215.
How much would €1,000 invested in EVT at IPO be worth today? ▼
If you invested €1,000 in EVT at its IPO in 1999, it would be worth approximately €235 today, a -76.5% return over 27 years.
Does EVT pay dividends? ▼
No, Evotec SE does not currently pay a dividend. The company reinvests its earnings into growth.
What is EVT's market cap? ▼
Evotec SE has a market capitalization of €742 million, classifying it as a small-cap company.
Is EVT a buy, hold, or sell? ▼
Based on 6 opinions, EVT has a consensus "buy" rating. The average price target is €6.97.
Last updated: 3/15/2026